Turn on, tune in: New York biotech scores $15M+ in chemogenetics bet
Typically, once a biological target has been identified, scientists work on developing molecules focused on that target. But in an emerging field called chemogenetics, researchers …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
